Login

Switch On Your HIV Smarts.

HIV and Cardiovascular Risk: Early Statin Use May Help

HIV and Cardiovascular Risk: Early Statin Use May Help

, by Emily Newman

Cholesterol-lowering drugs may help people with HIV mitigate heightened risk of heart trouble. Read More

Abdominal Body Fat Gains on ART and Viral Load: It Matters Where You Start

Abdominal Body Fat Gains on ART and Viral Load: It Matters Where You Start

, by Emily Newman

Gains in abdominal body fat and other types of lipodystrophy can be one side effect of antiretroviral therapy. New research gives insight into one potential cause. Read More

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

, by Liz Highleyman

What’s new in the world of HIV drug development? CROI brought us updates on a potentially safer version of tenofovir and a new type of drug that just established proof-of-concept. Read More

CROI 2015: “On-Demand” PrEP Shows High Efficacy in IPERGAY Trial

CROI 2015: “On-Demand” PrEP Shows High Efficacy in IPERGAY Trial

, by Emily Newman

Exciting results from the IPERGAY study—on the effectiveness of intermittent PrEP—were recently announced. Read More

CROI 2015: Partners PrEP Demo project: Near Elimination of HIV Transmission with ART and PrEP

CROI 2015: Partners PrEP Demo project: Near Elimination of HIV Transmission with ART and PrEP

, by Emily Newman

New data from CROI show that that PrEP is effective as a temporary “bridge” in serodiscordant couples until viral suppression is achieved. Read More